EUVIMEDEUVIMED entdecken
Editorial

Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance

Nora Janjan

ONCOLOGY · 11.06.2026 · 40 (5) · 220

DOI: 10.46883/2026.25921214 ↗

Kurz gefasst

Editorial in der Zeitschrift ONCOLOGY, online erschienen am 06.07.2026. Verfasst von Nora Janjan. Hauptthemen laut MEDLINE: Drug Costs, Health Services Accessibility, Antineoplastic Agents. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A primary driver of skyrocketing health care budgets has been the cost of prescription medications, which is particularly true for oncology, as personalized medicine is the standard of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CostsHealth Services AccessibilityAntineoplastic AgentsHumans

Substanzen

Antineoplastic Agents

Zitieren

APA

Janjan, N. (2026). Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance. ONCOLOGY, 40(5), 220. https://doi.org/10.46883/2026.25921214

Vancouver

Janjan N. Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance. ONCOLOGY. 2026;40(5):220. doi:10.46883/2026.25921214

BibTeX
@article{Janjan2026,
  author = {Janjan, Nora},
  title = {Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance},
  journal = {ONCOLOGY},
  year = {2026},
  volume = {40},
  number = {5},
  pages = {220},
  doi = {10.46883/2026.25921214}
}
Kostenlos starten →